Inflammation as a Possible Trigger for Mitoxantrone-Induced Cardiotoxicity: An In Vivo Study in Adult and Infant Mice

Mitoxantrone (MTX) is a pharmaceutical drug used in the treatment of several cancers and refractory multiple sclerosis (MS). Despite its therapeutic value, adverse effects may be severe, namely the frequently reported cardiotoxicity, whose mechanisms need further research. This work aimed to assess...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ana Reis-Mendes, José Luís Dores-Sousa, Ana Isabel Padrão, Margarida Duarte-Araújo, José Alberto Duarte, Vítor Seabra, Salomé Gonçalves-Monteiro, Fernando Remião, Félix Carvalho, Emília Sousa, Maria Lourdes Bastos, Vera Marisa Costa
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2021-05-01
Series:	Pharmaceuticals
Assuntos:	mitoxantrone cardiotoxicity inflammation oxidative stress age cumulative dose
Acceso en liña:	https://www.mdpi.com/1424-8247/14/6/510
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!